Oncology & Cancer

Few high-grade soft tissue sarcoma patients receive chemo

(HealthDay)—The rates of adults with high-grade soft tissue sarcoma (STS) who receive chemotherapy may be lower than expected, indicating a need for more aggressive systemic treatments, according to a study published in ...

Oncology & Cancer

Study shows genetic effects of pre-surgical chemo in breast cancer

Results from one of the first studies to determine the effects of pre-surgical, or neoadjuvant, chemotherapy on the breast cancer genome offer up two key insights. One is a before treatment finding that can help predict which ...

Oncology & Cancer

Less chemotherapy may have more benefit in rectal cancer

Chemotherapy used to shrink a tumor before surgery, called neoadjuvant chemotherapy, is becoming more common in many cancers, including stage II and III rectal cancer. However, the chemotherapy regimens FOLFOX and CapeOx ...

page 1 from 6